Modulation of Ca2+ Signaling by Anti-apoptotic B-Cell Lymphoma 2 Proteins at the Endoplasmic Reticulum–Mitochondrial Interface

Mitochondria are important regulators of cell death and cell survival. Mitochondrial Ca2+ levels are critically involved in both of these processes. On the one hand, excessive mitochondrial Ca2+ leads to Ca2+-induced mitochondrial outer membrane permeabilization and thus apoptosis. On the other hand, mitochondria need Ca2+ in order to efficiently fuel the tricarboxylic acid cycle and maintain adequate mitochondrial bioenergetics. For obtaining this Ca2+, the mitochondria are largely dependent on close contact sites with the endoplasmic reticulum (ER), the so-called mitochondria-associated ER membranes. There, the inositol 1,4,5-trisphosphate receptors are responsible for the Ca2+ release from the ER. It comes as no surprise that this Ca2+ release from the ER and the subsequent Ca2+ uptake at the mitochondria are finely regulated. Cancer cells often modulate ER-Ca2+ transfer to the mitochondria in order to promote cell survival and to inhibit cell death. Important regulators of these Ca2+ signals and the onset of cancer are the B-cell lymphoma 2 (Bcl-2) family of proteins. An increasing number of reports highlight the ability of these Bcl-2-protein family members to finely regulate Ca2+ transfer from ER to mitochondria both in healthy cells and in cancer. In this review, we focus on recent insights into the dynamic regulation of ER-mitochondrial Ca2+ fluxes by Bcl-2-family members and how this impacts cell survival, cell death and mitochondrial energy production.

[1]  J. Parys,et al.  The selective Bcl-2 inhibitor venetoclax, a BH3 mimetic, does not dysregulate intracellular Ca2+ signaling. , 2017, Biochimica et biophysica acta. Molecular cell research.

[2]  Ye Xu,et al.  ABT737 reverses cisplatin resistance by regulating ER-mitochondria Ca2+ signal transduction in human ovarian cancer cells. , 2016, International journal of oncology.

[3]  A. Strasser,et al.  The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models , 2016, Nature.

[4]  J. Parys,et al.  Bcl-2 proteins and calcium signaling: complexity beneath the surface , 2016, Oncogene.

[5]  J. Parys,et al.  The trans-membrane domain of Bcl-2α, but not its hydrophobic cleft, is a critical determinant for efficient IP3 receptor inhibition , 2016, Oncotarget.

[6]  D. Green A BH3 Mimetic for Killing Cancer Cells , 2016, Cell.

[7]  P. Pinton,et al.  ER functions of oncogenes and tumor suppressors: Modulators of intracellular Ca(2+) signaling. , 2016, Biochimica et biophysica acta.

[8]  M. Hoth CRAC channels, calcium, and cancer in light of the driver and passenger concept. , 2016, Biochimica et biophysica acta.

[9]  Rita Padányi,et al.  Multifaceted plasma membrane Ca(2+) pumps: From structure to intracellular Ca(2+) handling and cancer. , 2016, Biochimica et biophysica acta.

[10]  R. Rao,et al.  Calcium-ATPases: Gene disorders and dysregulation in cancer. , 2016, Biochimica et biophysica acta.

[11]  Na Ye,et al.  BH4 domain of Bcl-2 as a novel target for cancer therapy. , 2016, Drug discovery today.

[12]  J. Foskett,et al.  InsP3R, the calcium whisperer: Maintaining mitochondrial function in cancer , 2016, Molecular & cellular oncology.

[13]  M. Betenbaugh,et al.  The non-apoptotic action of Bcl-xL: regulating Ca2+ signaling and bioenergetics at the ER-mitochondrion interface , 2016, Journal of Bioenergetics and Biomembranes.

[14]  G. Bultynck Onco-IP3Rs Feed Cancerous Cravings for Mitochondrial Ca(2.). , 2016, Trends in biochemical sciences.

[15]  S. Lonial,et al.  BCL2-BH4 antagonist BDA-366 suppresses human myeloma growth , 2016, Oncotarget.

[16]  J. Diehl,et al.  Selective Vulnerability of Cancer Cells by Inhibition of Ca(2+) Transfer from Endoplasmic Reticulum to Mitochondria. , 2016, Cell reports.

[17]  J. Foskett,et al.  Biphasic regulation of InsP3 receptor gating by dual Ca2+ release channel BH3-like domains mediates Bcl-xL control of cell viability , 2016, Proceedings of the National Academy of Sciences.

[18]  P. Pinton,et al.  Mcl-1 involvement in mitochondrial dynamics is associated with apoptotic cell death , 2016, Molecular biology of the cell.

[19]  G. Wildey,et al.  Synergistic killing of human small cell lung cancer cells by the Bcl-2-inositol 1,4,5-trisphosphate receptor disruptor BIRD-2 and the BH3-mimetic ABT-263 , 2015, Cell Death and Disease.

[20]  G. Bultynck,et al.  Antagonizing Bcl-2′s BH4 domain in cancer , 2015, Aging.

[21]  V. Shoshan-Barmatz,et al.  The mitochondrial voltage-dependent anion channel 1 in tumor cells. , 2015, Biochimica et biophysica acta.

[22]  P. Pinton,et al.  Novel frontiers in calcium signaling: A possible target for chemotherapy. , 2015, Pharmacological research.

[23]  J. Pink,et al.  A synthetic peptide targeting the BH4 domain of Bcl-2 induces apoptosis in multiple myeloma and follicular lymphoma cells alone or in combination with agents targeting the BH3-binding pocket of Bcl-2 , 2015, Oncotarget.

[24]  Guangyi Wang,et al.  ABT737 enhances cholangiocarcinoma sensitivity to cisplatin through regulation of mitochondrial dynamics. , 2015, Experimental cell research.

[25]  Á. Almeida,et al.  Regulation of Bcl-xL–ATP Synthase Interaction by Mitochondrial Cyclin B1–Cyclin-Dependent Kinase-1 Determines Neuronal Survival , 2015, The Journal of Neuroscience.

[26]  W. Curran,et al.  Small-Molecule Bcl2 BH4 Antagonist for Lung Cancer Therapy. , 2015, Cancer cell.

[27]  P. Pinton,et al.  Mitochondria-associated membranes: composition, molecular mechanisms, and physiopathological implications. , 2015, Antioxidants & redox signaling.

[28]  G. Bultynck,et al.  p53 and Ca2+ signaling from the endoplasmic reticulum: partners in anti-cancer therapies , 2015, Oncoscience.

[29]  L. Walensky,et al.  Inhibition of Pro-apoptotic BAX by a noncanonical interaction mechanism. , 2015, Molecular cell.

[30]  P. Agostinis,et al.  The BH4 Domain of Anti-apoptotic Bcl-XL, but Not That of the Related Bcl-2, Limits the Voltage-dependent Anion Channel 1 (VDAC1)-mediated Transfer of Pro-apoptotic Ca2+ Signals to Mitochondria* , 2015, The Journal of Biological Chemistry.

[31]  G. Hankins,et al.  The BRCA1 Tumor Suppressor Binds to Inositol 1,4,5-Trisphosphate Receptors to Stimulate Apoptotic Calcium Release* , 2015, The Journal of Biological Chemistry.

[32]  F. Mammano,et al.  p53 at the endoplasmic reticulum regulates apoptosis in a Ca2+-dependent manner , 2015, Proceedings of the National Academy of Sciences.

[33]  F. Mammano,et al.  Intravital imaging reveals p53-dependent cancer cell death induced by phototherapy via calcium signaling , 2014, Oncotarget.

[34]  N. Bradbury,et al.  Mcl-1 promotes lung cancer cell migration by directly interacting with VDAC to increase mitochondrial Ca2+ uptake and reactive oxygen species generation , 2014, Cell Death and Disease.

[35]  M. Benahmed,et al.  Remodeling of channel-forming ORAI proteins determines an oncogenic switch in prostate cancer. , 2014, Cancer cell.

[36]  S. Grimm,et al.  Mitochondrial Ca2+ influx targets cardiolipin to disintegrate respiratory chain complex II for cell death induction , 2014, Cell Death and Differentiation.

[37]  M. Betenbaugh,et al.  Bcl-2 family in inter-organelle modulation of calcium signaling; roles in bioenergetics and cell survival , 2014, Journal of Bioenergetics and Biomembranes.

[38]  Chi Li,et al.  An Interaction between Bcl-xL and the Voltage-dependent Anion Channel (VDAC) Promotes Mitochondrial Ca2+ Uptake* , 2013, The Journal of Biological Chemistry.

[39]  K. Mikoshiba,et al.  IP3R2 levels dictate the apoptotic sensitivity of diffuse large B-cell lymphoma cells to an IP3R-derived peptide targeting the BH4 domain of Bcl-2 , 2013, Cell Death and Disease.

[40]  G. Bultynck,et al.  Altered Ca(2+) signaling in cancer cells: proto-oncogenes and tumor suppressors targeting IP3 receptors. , 2013, Biochimica et biophysica acta.

[41]  G. Bultynck,et al.  The selective BH4-domain biology of Bcl-2-family members: IP3Rs and beyond , 2013, Cellular and Molecular Life Sciences.

[42]  V. Giorgio,et al.  Dimers of mitochondrial ATP synthase form the permeability transition pore , 2013, Proceedings of the National Academy of Sciences.

[43]  John M. Ashton,et al.  BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. , 2013, Cell stem cell.

[44]  L. Galluzzi,et al.  Role of the c subunit of the FO ATP synthase in mitochondrial permeability transition , 2013, Cell cycle.

[45]  L. Lam,et al.  ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets , 2013, Nature Medicine.

[46]  L. Missiaen,et al.  Profiling of the Bcl-2/Bcl-X(L)-binding sites on type 1 IP(3) receptor. , 2012, Biochemical and biophysical research communications.

[47]  A. Letai,et al.  Targeting the B-cell lymphoma/leukemia 2 family in cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  Rosario Rizzuto,et al.  Mitochondria as sensors and regulators of calcium signalling , 2012, Nature Reviews Molecular Cell Biology.

[49]  F. Davis,et al.  Calcium Channels and Pumps in Cancer: Changes and Consequences* , 2012, The Journal of Biological Chemistry.

[50]  V. Shoshan-Barmatz,et al.  Mediation of the Antiapoptotic Activity of Bcl-xL Protein upon Interaction with VDAC1 Protein* , 2012, The Journal of Biological Chemistry.

[51]  Daniel P. Stewart,et al.  Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration , 2012, Nature Cell Biology.

[52]  R. Balaban,et al.  Role of mitochondrial Ca2+ in the regulation of cellular energetics. , 2012, Biochemistry.

[53]  S. Grimm The ER-mitochondria interface: the social network of cell death. , 2012, Biochimica et biophysica acta.

[54]  L. Kaczmarek,et al.  Bcl-xL regulates mitochondrial energetics by stabilizing the inner membrane potential , 2011, The Journal of cell biology.

[55]  M. Bootman,et al.  Bcl-2 interaction with the inositol 1,4,5-trisphosphate receptor: role in Ca(2+) signaling and disease. , 2011, Cell calcium.

[56]  A. Roberts,et al.  Bcl-xL-inhibitory BH3 mimetics can induce a transient thrombocytopathy that undermines the hemostatic function of platelets. , 2011, Blood.

[57]  M. de Maeyer,et al.  Selective regulation of IP3-receptor-mediated Ca2+ signaling and apoptosis by the BH4 domain of Bcl-2 versus Bcl-Xl , 2011, Cell Death and Differentiation.

[58]  Shanta M. Messerli,et al.  Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthase , 2011, Nature Cell Biology.

[59]  Peifang Liu,et al.  Functional SNP in the microRNA-367 binding site in the 3′UTR of the calcium channel ryanodine receptor gene 3 (RYR3) affects breast cancer risk and calcification , 2011, Proceedings of the National Academy of Sciences.

[60]  N. Prevarskaya,et al.  Calcium in tumour metastasis: new roles for known actors , 2011, Nature Reviews Cancer.

[61]  I. Ambudkar,et al.  Faculty Opinions recommendation of A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. , 2011 .

[62]  V. Mootha,et al.  Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter , 2011, Nature.

[63]  P. Pinton,et al.  Mitochondria associated membranes (MAMs) as critical hubs for apoptosis , 2011, Communicative & Integrative Biology.

[64]  J. Parys,et al.  Induction of Ca²+-driven apoptosis in chronic lymphocytic leukemia cells by peptide-mediated disruption of Bcl-2-IP3 receptor interaction. , 2011, Blood.

[65]  D. Green,et al.  Apoptosis and oncogenesis: give and take in the BCL-2 family. , 2011, Current opinion in genetics & development.

[66]  P. Kenny,et al.  ORAI1-Mediated Calcium Influx in Lactation and in Breast Cancer , 2011, Molecular Cancer Therapeutics.

[67]  C. Distelhorst,et al.  Apoptosis and autophagy: decoding calcium signals that mediate life or death. , 2010, Cold Spring Harbor perspectives in biology.

[68]  M. Birnbaum,et al.  Essential Regulation of Cell Bioenergetics by Constitutive InsP3 Receptor Ca2+ Transfer to Mitochondria , 2010, Cell.

[69]  D. Andrews,et al.  Bcl-2 and Bax Interact via the BH1–3 Groove-BH3 Motif Interface and a Novel Interface Involving the BH4 Motif* , 2010, The Journal of Biological Chemistry.

[70]  V. De Pinto,et al.  VDAC, a multi-functional mitochondrial protein regulating cell life and death. , 2010, Molecular aspects of medicine.

[71]  J. Foskett,et al.  Apoptosis Protection by Mcl-1 and Bcl-2 Modulation of Inositol 1,4,5-Trisphosphate Receptor-dependent Ca2+ Signaling* , 2010, The Journal of Biological Chemistry.

[72]  D. Green,et al.  The BCL-2 family reunion. , 2010, Molecular cell.

[73]  Derek Y. Chiang,et al.  The landscape of somatic copy-number alteration across human cancers , 2010, Nature.

[74]  V. Shoshan-Barmatz,et al.  Voltage-dependent Anion Channel 1-based Peptides Interact with Bcl-2 to Prevent Antiapoptotic Activity* , 2009, The Journal of Biological Chemistry.

[75]  M. Bootman,et al.  The BH4 domain of Bcl-2 inhibits ER calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptor , 2009, Proceedings of the National Academy of Sciences.

[76]  P. M. Hwang,et al.  The Krebs cycle meets the cell cycle: Mitochondria and the G1–S transition , 2009, Proceedings of the National Academy of Sciences.

[77]  V. Yee,et al.  Targeting Bcl-2 based on the interaction of its BH4 domain with the inositol 1,4,5-trisphosphate receptor. , 2009, Biochimica et biophysica acta.

[78]  V. Shoshan-Barmatz,et al.  The VDAC1 N-terminus is essential both for apoptosis and the protective effect of anti-apoptotic proteins , 2009, Journal of Cell Science.

[79]  A. Letai,et al.  Control of mitochondrial apoptosis by the Bcl-2 family , 2009, Journal of Cell Science.

[80]  J. Foskett,et al.  Bcl-xL Regulation of InsP3 Receptor Gating Mediated by Dual Ca2+ Release Channel BH3 Domains , 2009 .

[81]  John Calvin Reed,et al.  Bcl-2 family proteins and cancer , 2008, Oncogene.

[82]  M. Berridge,et al.  The versatility and complexity of calcium signalling. , 2008, Novartis Foundation symposium.

[83]  M. Bootman,et al.  Bcl-2 suppresses Ca2+ release through inositol 1,4,5-trisphosphate receptors and inhibits Ca2+ uptake by mitochondria without affecting ER calcium store content. , 2008, Cell calcium.

[84]  Xiang Li,et al.  Targeting Bcl-2-IP3 receptor interaction to reverse Bcl-2's inhibition of apoptotic calcium signals. , 2008, Molecular cell.

[85]  H. Llewelyn Roderick,et al.  Ca2+ signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival , 2008, Nature Reviews Cancer.

[86]  Sarah J. Roberts-Thomson,et al.  Calcium and cancer: targeting Ca2+ transport , 2007, Nature Reviews Cancer.

[87]  P. Várnai,et al.  Chaperone-mediated coupling of endoplasmic reticulum and mitochondrial Ca2+ channels , 2006, The Journal of cell biology.

[88]  F. Zhong,et al.  Bcl-2 differentially regulates Ca2+ signals according to the strength of T cell receptor activation , 2006, The Journal of cell biology.

[89]  C. Thompson,et al.  The endoplasmic reticulum gateway to apoptosis by Bcl-XL modulation of the InsP3R , 2005, Nature Cell Biology.

[90]  S. Korsmeyer,et al.  An inhibitor of Bcl-2 family proteins induces regression of solid tumours , 2005, Nature.

[91]  M. Berridge,et al.  Bcl-2 functionally interacts with inositol 1,4,5-trisphosphate receptors to regulate calcium release from the ER in response to inositol 1,4,5-trisphosphate , 2004, The Journal of cell biology.

[92]  G. Shore,et al.  Bcl-2 and calcium: controversy beneath the surface , 2004, Oncogene.

[93]  Masashi Narita,et al.  Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC , 1999, Nature.

[94]  J. Parys,et al.  Inositol 1,4,5-trisphosphate and its receptors. , 2012, Advances in experimental medicine and biology.